349 related articles for article (PubMed ID: 35070035)
1. Solid extraintestinal malignancies in patients with inflammatory bowel disease.
Mala A; Foteinogiannopoulou K; Koutroubakis IE
World J Gastrointest Oncol; 2021 Dec; 13(12):1956-1980. PubMed ID: 35070035
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
3. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.
Chang M; Chang L; Chang HM; Chang F
Clin Colorectal Cancer; 2018 Mar; 17(1):e29-e37. PubMed ID: 28712945
[TBL] [Abstract][Full Text] [Related]
4. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
Massano A; Bertin L; Zingone F; Buda A; Visaggi P; Bertani L; de Bortoli N; Fassan M; Scarpa M; Ruffolo C; Angriman I; Bezzio C; Casini V; Ribaldone DG; Savarino EV; Barberio B
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568640
[TBL] [Abstract][Full Text] [Related]
5. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
[TBL] [Abstract][Full Text] [Related]
6. The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies.
Lo B; Zhao M; Vind I; Burisch J
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1117-1138.e19. PubMed ID: 32801010
[TBL] [Abstract][Full Text] [Related]
7. Malignancies in inflammatory bowel disease.
Nieminen U; Färkkilä M
Scand J Gastroenterol; 2015 Jan; 50(1):81-9. PubMed ID: 25523559
[TBL] [Abstract][Full Text] [Related]
8. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
9. Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?
Garg SK; Loftus EV
Curr Opin Gastroenterol; 2016 Jul; 32(4):274-81. PubMed ID: 27152873
[TBL] [Abstract][Full Text] [Related]
10. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of inflammatory bowel disease in the organ recipient.
Indriolo A; Ravelli P
World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
[TBL] [Abstract][Full Text] [Related]
14. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
Parian A; Lazarev M
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and the pathogenesis of inflammatory bowel disease.
Karlinger K; Györke T; Makö E; Mester A; Tarján Z
Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
[TBL] [Abstract][Full Text] [Related]
16. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
17. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Fousekis FS; Theopistos VI; Mitselos IV; Skamnelos A; Kavvadias A; Katsanos KH; Christodoulou DK
J Clin Med Res; 2019 Feb; 11(2):81-88. PubMed ID: 30700999
[TBL] [Abstract][Full Text] [Related]
18. Patient awareness of extraintestinal manifestations of inflammatory bowel disease.
Huang V; Mishra R; Thanabalan R; Nguyen GC
J Crohns Colitis; 2013 Sep; 7(8):e318-24. PubMed ID: 23265763
[TBL] [Abstract][Full Text] [Related]
19. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
Fousekis FS; Theopistos VI; Katsanos KH; Tsianos EV; Christodoulou DK
Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
